Decades of work on chronic obstructive pulmondary disease (COPD) at the Jacobs School of Medicine and Biomedical Sciences and the Veterans Affairs Western New York Healthcare System have yielded extraordinary information about the bacterial pathogen that does the most harm to patients.
Five research projects that aim to improve our understanding of the human microbiome have been selected to receive the first round of funding from the Community of Excellence in Genome, Environment and Microbiome (GEM).
Aspiring physician-scientists showcased 38 original research projects at the 2016 Medical Student Research Forum. The displays showed work they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.
Award-winning participants in the Department of Medicine’s second annual Research Day are studying diverse topics, including disease processes for atrial fibrillation; treatments for leukemia, diabetes and COPD; and the need for cortisol.
University at Buffalo researchers have revealed that patients with chronic obstructive pulmonary disease (COPD) experience more respiratory symptoms when their lungs are colonized by bacteria, even without an acute exacerbation.
At the 2014 Medical Student Research Forum, aspiring physician-scientists showcased 34 original research projects they conducted at the University at Buffalo, its partner health care agencies and institutions nationwide.
University at Buffalo scientists will continue nearly three decades of groundbreaking research on a bacterium considered a key cause of the hallmark signs of chronic obstructive pulmonary disease (COPD).
Based on their published scientific articles, two University at Buffalo physician-scientists have been recognized as leading investigators in their medical specialties by the global health care information website Expertscape.